Skip to content

Evaluation of safety and efficacy of Remazolam toluene sulfonate for bronchoscopic alveolar lavage in patients with severe pneumonia

Evaluation of safety and efficacy of Remazolam toluene sulfonate for bronchoscopic alveolar lavage in patients with severe pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095854
Enrollment
Unknown
Registered
2025-01-14
Start date
2024-09-27
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pneumonia caused by various pathogens

Interventions

Remazolam Tosilate for injection sedation group:Remazolam Tosilate for Injection

Sponsors

affiliated hospital of jining medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meeting the diagnostic criteria for severe pneumonia (China 2015 Adult CAP Guidelines adopt a new simplified diagnostic criteria: Those who meet 1 of the following major criteria or =3 minor criteria can be diagnosed with severe pneumonia. Main criteria: (1) Tracheal intubation requires mechanical ventilation; (2) Vasoactive drugs are still needed after active humoral resuscitation of septic shock. Secondary criteria: (1) Respiratory rate >30 times /min;(2) PaO2/FiO2=7 mmol/L; (6) hypotension requires active fluid resuscitation, 2. ASA grade II to IV, 3. age 18 to 80, 4. voluntarily sign the "Informed Consent for medium depth sedation and analgesia" and "Informed Consent for bronchoscopy and alveolar lavage".

Exclusion criteria

Exclusion criteria: 1. Allergic to the experimental drug; 2. Previous history of special anesthesia; 3. Preoperative circulatory instability; 4. Patients with abnormal coagulation function and high risk of bleeding; 5. Suspected difficult airway; 6. Myasthenia gravis, schizophrenia, severe depression; 7. Pregnant women;

Design outcomes

Primary

MeasureTime frame
Time of onset of sedation;awakening time;

Secondary

MeasureTime frame
heart rate;blood pressure;Pulse blood oxygen saturation;

Countries

China

Contacts

Public ContactLi Ruomeng

affiliated hospital of jining medical university

liruomeng120@163.com+86 537 2903353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026